Other OTC - Delayed Quote USD

IDenta Corp. (IDTA)

0.2175 0.0000 (0.00%)
At close: April 23 at 2:55 PM EDT
Advanced Chart
Loading Chart for IDTA
DELL
  • Previous Close 0.2175
  • Open 0.2200
  • Bid --
  • Ask --
  • Day's Range 0.2175 - 0.2175
  • 52 Week Range 0.1000 - 0.7500
  • Volume 1,800
  • Avg. Volume 330
  • Market Cap (intraday) 879,915
  • Beta (5Y Monthly) 1.74
  • PE Ratio (TTM) ∞
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

IDenta Corp. operates as a detection and forensic science company. The company offers drug, explosives, bullet-hole testing, and phenolphthalein blood detection kits; aero chamber sniffer; and FerroPrint testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company has operations in the Israel, United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Nigeria, Canada, and internationally. IDenta Corp. was founded in 2002 and is headquartered in Jerusalem, Israel.

www.identa-corp.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Diagnostics & Research

Industry

More about IDenta Corp.

Recent News: IDTA

View More
View More

Performance Overview: IDTA

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IDTA
72.62%
S&P 500
6.33%

1-Year Return

IDTA
37.86%
S&P 500
22.70%

3-Year Return

IDTA
85.20%
S&P 500
21.33%

5-Year Return

IDTA
8.75%
S&P 500
72.88%

Compare To: IDTA

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

IDTA
IDenta Corp.
0.2175
0.00%
Mkt Cap 879,915
Industry Diagnostics & Research
TRIB
Trinity Biotech plc
1.8300
-1.08%
Mkt Cap 13.984M
Industry Diagnostics & Research

Statistics: IDTA

View More

Valuation Measures

Annual
As of 4/23/2024

  • Market Cap

    879.91k

  • Enterprise Value

    1.40M

  • Trailing P/E

    72.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.98

  • Price/Book (mrq)

    1.70

  • Enterprise Value/Revenue

    1.33

  • Enterprise Value/EBITDA

    19.57

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.15%

  • Return on Assets (ttm)

    5.62%

  • Return on Equity (ttm)

    36.58%

  • Revenue (ttm)

    1.34M

  • Net Income Avi to Common (ttm)

    162.71k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    39.44k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    105.89k

View More

Company Insights: IDTA

People Also Watch

HTDS Hard to Treat Diseases Inc.
0.0000
0.00%
 
ASFX American Scientific Resources, Incorporated
0.0001
0.00%
 
IGNT Ingen Technologies, Inc.
0.0000
0.00%
 
MSITF Medical Services International Inc.
0.0000
0.00%
 
OWVI One World Ventures, Inc.
0.0190
0.00%
 
LLBO Lifeline Biotechnologies, Inc.
0.0002
0.00%
 
PDMI Paradigm Medical Industries, Inc.
0.0002
0.00%
 
EESO Enzyme Environmental Solutions, Inc.
0.0000
0.00%
 
WNBD Winning Brands Corporation
0.0002
+50.00%
 
MGLG Magellan Energy, Ltd.
0.0000
0.00%
 
CWIR Central Wireless, Inc.
0.0000
0.00%
 
GERS CleanTech Alpha Corporation
0.0639
0.00%
 
HESG Health Sciences Group, Inc.
0.0000
0.00%
 
EXPH Expo Holdings, Inc.
0.0000
0.00%
 
ICBT ICBS, Ltd.
0.0000
0.00%
 
INAR InternetArray, Inc.
0.0000
0.00%